216 related articles for article (PubMed ID: 7537306)
1. Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent.
Zahalka MA; Okon E; Gosslar U; Holzmann B; Naor D
J Immunol; 1995 May; 154(10):5345-55. PubMed ID: 7537306
[TBL] [Abstract][Full Text] [Related]
2. Blocking lymphoma invasiveness with a monoclonal antibody directed against the beta-chain of the leukocyte adhesion molecule (CD18).
Zahalka MA; Okon E; Naor D
J Immunol; 1993 May; 150(10):4466-77. PubMed ID: 8097756
[TBL] [Abstract][Full Text] [Related]
3. Beta 2-integrin dependent aggregate formation between LB T cell lymphoma and spleen cells: assessment of correlation with spleen invasiveness.
Zahalka MA; Naor D
Int Immunol; 1994 Jun; 6(6):917-24. PubMed ID: 7522049
[TBL] [Abstract][Full Text] [Related]
4. The CD44 receptor of the mouse LB T-cell lymphoma: analysis of the isoform repertoire and ligand binding properties by reverse-transcriptase polymerase chain reaction and antisense oligonucleotides.
Wallach SB; Friedmann A; Naor D
Cancer Detect Prev; 2000; 24(1):33-45. PubMed ID: 10757121
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronan-independent lodgment of CD44+ lymphoma cells in lymphoid organs.
Vogt Sionov R; Naor D
Int J Cancer; 1997 May; 71(3):462-9. PubMed ID: 9139885
[TBL] [Abstract][Full Text] [Related]
6. CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells.
Lesley J; Hyman R
Eur J Immunol; 1992 Oct; 22(10):2719-23. PubMed ID: 1382996
[TBL] [Abstract][Full Text] [Related]
7. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2.
Lin J; Yon RW; Chavin KD; Qin L; Woodward J; Ding Y; Yagita H; Bromberg JS
Transplantation; 1995 Apr; 59(8):1162-71. PubMed ID: 7537394
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells.
Galandrini R; Galluzzo E; Albi N; Grossi CE; Velardi A
J Immunol; 1994 Jul; 153(1):21-31. PubMed ID: 7515923
[TBL] [Abstract][Full Text] [Related]
9. Involvement of CD44, a molecule with a thousand faces, in cancer dissemination.
Naor D; Wallach-Dayan SB; Zahalka MA; Sionov RV
Semin Cancer Biol; 2008 Aug; 18(4):260-7. PubMed ID: 18467123
[TBL] [Abstract][Full Text] [Related]
10. VCAM-1 is not involved in LPAM-1 (alpha 4 beta p/alpha 4 beta 7) mediated binding of lymphoma cells to high endothelial venules of mucosa-associated lymph nodes.
Hahne M; Lenter M; Jäger U; Isenmann S; Vestweber D
Eur J Cell Biol; 1993 Aug; 61(2):290-8. PubMed ID: 7693472
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells.
Asplund T; Heldin P
Cancer Res; 1994 Aug; 54(16):4516-23. PubMed ID: 7519123
[TBL] [Abstract][Full Text] [Related]
12. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
13. TABS, a T cell activation antigen that induces LFA-1-dependent aggregation.
Andrew DP; Yoshino T; Guh L; Martin-Simonet MT; Butcher EC
J Immunol; 1995 Aug; 155(4):1671-84. PubMed ID: 7543529
[TBL] [Abstract][Full Text] [Related]
14. Adhesion molecule expression does not influence the leukemic behavior of murine T-cell lymphomas.
Dolcetti R; Maestro R; Gasparotto D; Rizzo S; Boiocchi M
Leukemia; 1992; 6 Suppl 3():101S-105S. PubMed ID: 1351121
[TBL] [Abstract][Full Text] [Related]
15. Disruption of T lymphocyte reappearance in anti-Thy-1-treated animals in vivo with soluble CD44 and L-selectin molecules.
Guo YJ; Wong JH; Lin SC; Aruffo A; Stamenkovic I; Sy MS
Cell Immunol; 1994 Mar; 154(1):202-18. PubMed ID: 7509728
[TBL] [Abstract][Full Text] [Related]
16. Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody.
Lesley J; Kincade PW; Hyman R
Eur J Immunol; 1993 Aug; 23(8):1902-9. PubMed ID: 7688309
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.
Fujita N; Yaegashi N; Ide Y; Sato S; Nakamura M; Ishiwata I; Yajima A
Cancer Res; 1994 Jul; 54(14):3922-8. PubMed ID: 7518345
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody.
Guo Y; Ma J; Wang J; Che X; Narula J; Bigby M; Wu M; Sy MS
Cancer Res; 1994 Mar; 54(6):1561-5. PubMed ID: 7511044
[TBL] [Abstract][Full Text] [Related]
19. CD44 is a cytotoxic triggering molecule in human peripheral blood NK cells.
Sconocchia G; Titus JA; Segal DM
J Immunol; 1994 Dec; 153(12):5473-81. PubMed ID: 7527443
[TBL] [Abstract][Full Text] [Related]
20. High endothelial venules and cell adhesion molecules in B-cell chronic lymphocytic leukaemia and related low grade B-cell lymphoma/leukaemia: II. Expression of cell adhesion molecules in lymph nodes biopsies.
Csanaky G
Histol Histopathol; 1994 Jul; 9(3):577-82. PubMed ID: 7526911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
